Giulia Vivaldi
Overview
Explore the profile of Giulia Vivaldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chambers E, Cai W, Vivaldi G, Jolliffe D, Perdek N, Li W, et al.
NPJ Vaccines
. 2024 May;
9(1):87.
PMID: 38778017
Vaccine development targeting SARS-CoV-2 in 2020 was of critical importance in reducing COVID-19 severity and mortality. In the U.K. during the initial roll-out most individuals either received two doses of...
2.
Hajmohammadi H, Talaei M, Fecht D, Wang W, Vivaldi G, Faustini S, et al.
Respir Med
. 2024 Feb;
224:107567.
PMID: 38423343
Background: The association between air quality and risk of SARS-CoV-2 infection is poorly understood. We investigated this association using serological individual-level data adjusting for a wide range of confounders, in...
3.
Vivaldi G, Pfeffer P, Talaei M, Basera T, Shaheen S, Martineau A
EClinicalMedicine
. 2023 Dec;
65:102251.
PMID: 38106559
Background: Long COVID is a well recognised, if heterogeneous, entity. Acute respiratory infections (ARIs) due to other pathogens may cause long-term symptoms, but few studies compare post-acute sequelae between SARS-CoV-2...
4.
Zheng B, Vivaldi G, Daines L, Leavy O, Richardson M, Elneima O, et al.
Lancet Reg Health Eur
. 2023 Jun;
29:100635.
PMID: 37261214
Background: The risk factors for recovery from COVID-19 dyspnoea are poorly understood. We investigated determinants of recovery from dyspnoea in adults with COVID-19 and compared these to determinants of recovery...
5.
Holt H, Jolliffe D, Talaei M, Faustini S, Vivaldi G, Greenig M, et al.
NPJ Vaccines
. 2023 Feb;
8(1):26.
PMID: 36841835
Prospective population-based studies investigating associations between reactive symptoms following SARS-CoV-2 vaccination and serologic responses to vaccination are lacking. We therefore conducted a study in 9003 adults from the UK general...
6.
Tydeman F, Pfeffer P, Vivaldi G, Holt H, Talaei M, Jolliffe D, et al.
Thorax
. 2022 Nov;
78(8):752-759.
PMID: 36423925
Background: The imposition of restrictions on social mixing early in the COVID-19 pandemic was followed by a reduction in asthma exacerbations in multiple settings internationally. Temporal trends in social mixing,...
7.
Jolliffe D, Faustini S, Holt H, Perdek N, Maltby S, Talaei M, et al.
Vaccines (Basel)
. 2022 Oct;
10(10).
PMID: 36298466
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly understood. A range of sociodemographic, behavioural, clinical, pharmacologic and nutritional factors could explain these differences. To investigate this hypothesis,...
8.
Jolliffe D, Holt H, Greenig M, Talaei M, Perdek N, Pfeffer P, et al.
BMJ
. 2022 Oct;
378:e071230.
PMID: 36215226
Objective: To determine the effect of population level implementation of a test-and-treat approach to correction of suboptimal vitamin D status (25-hydroxyvitamin D (25(OH)D) <75 nmol/L) on risk of all cause...
9.
Holt H, Relton C, Talaei M, Symons J, Davies M, Jolliffe D, et al.
Int J Epidemiol
. 2022 Sep;
52(1):e46-e56.
PMID: 36174228
No abstract available.
10.
Vivaldi G, Jolliffe D, Holt H, Tydeman F, Talaei M, Davies G, et al.
Lancet Reg Health Eur
. 2022 Sep;
22:100501.
PMID: 36168404
Background: Little is known about how demographic, behavioural, and vaccine-related factors affect risk of post-vaccination SARS-CoV-2 infection. We aimed to identify risk factors for SARS-CoV-2 infection after primary and booster...